Over the last 12 months, one YD Bio Ltd company insiders bought shares at market prices, about $129,000 in total, and none of them sold.
Biggest single buyer: Shen Ethan PhD, CEO, with roughly $67,000. That includes C-suite money, which tends to get the most attention.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters. 12 investment managers listed YDES in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Shen Ethan PhD | CEO | Buy | 12,700 | $3.85 | $49K | SEC |
| Sep 10, 2026 | Shen Ethan PhD | CEO | Buy | 3,100 | $3.93 | $12K | SEC |
| Sep 8, 2026 | Shen Ethan PhD | CEO | Buy | 18,378 | $3.67 | $67K | SEC |
In the last 12 months YD Bio Ltd insiders made open-market purchases worth about $129,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in YDES was filed on 2026-09-16.
12 investment managers reported holding YDES in SEC Form 13F filings for Q2 2026.
No congressional trades in YDES were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).